Insider trading

Period: 120 months Stock: DXCM + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

605 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

605 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

605 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

605 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
605 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
605 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

605 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
8 Mar 2019
Murphy Patrick Michael SVP Legal Affairs
Sold, plan not stated
$56.62K 400 at 141.56
1.4%
22 Feb 2019
Pacelli Steven Robert EVP Strategy and Corporate Dev
Sold, plan not stated 6×
$241.16K 1,667 at 144.67
1.6%
15 Feb 2019
FOLETTA MARK G Director · indirect
Sold, plan not stated 2×
$148.72K 1,000 at 148.72
5.8%
11 Feb 2019
SAYER KEVIN R President, CEO and Chairman
Sold, plan not stated 3×
$893.40K 6,000 at 148.90
1.9%
8 Feb 2019
Murphy Patrick Michael SVP Legal Affairs
Sold, plan not stated 2×
$114.21K 800 at 142.76
2.7%
23 Jan 2019
Pacelli Steven Robert EVP, Strategy & Corp. Dev.
Sold, plan not stated
$466.30K 3,114 at 149.74
3.0%
14 Jan 2019
KAHN BARBARA Director · indirect
Sold, plan not stated 3×
$1.51M 10,631 at 142.30
38.7%
14 Jan 2019
SAYER KEVIN R President, CEO & Chairman
Sold, plan not stated 2×
$845.93K 6,000 at 140.99
1.9%
10 Jan 2019
Murphy Patrick Michael SVP, GC & Chief Compliance Off
Sold, plan not stated
$55.50K 400 at 138.75
1.3%
2 Jan 2019
ALTMAN STEVEN R Director · indirect
Sold, plan not stated
$292.59K 2,500 at 117.04
4.5%
21 Dec 2018
Pacelli Steven Robert EVP, Strategy & Corp. Dev.
Sold, plan not stated 3×
$340.70K 3,114 at 109.41
2.9%
21 Dec 2018
DOUBLEDAY RICHARD EVP, Chief Commercial Officer · indirect
Sold, plan not stated 3×
$165.10K 1,510 at 109.34
9.7%
14 Dec 2018
Balo Andrew K EVP, Reg. Strategy, Clinical
Sold, plan not stated 2×
$606.17K 5,000 at 121.23
6.4%
10 Dec 2018
SAYER KEVIN R President, CEO & Chairman
Sold, plan not stated 4×
$1.36M 11,162 at 121.67
3.4%
10 Dec 2018
Murphy Patrick Michael SVP, GC & Chief Compliance Off
Sold, plan not stated
$48.76K 400 at 121.90
1.3%
23 Nov 2018
Pacelli Steven Robert EVP, Strategy & Corp. Dev.
Sold, plan not stated 3×
$378.10K 3,114 at 121.42
2.8%
23 Nov 2018
DOUBLEDAY RICHARD EVP, Chief Commercial Officer · indirect
Sold, plan not stated 2×
$210.66K 1,736 at 121.35
10.0%
14 Nov 2018
Balo Andrew K EVP, Reg. Strategy, Clinical
Sold, plan not stated 4×
$715.66K 5,000 at 143.13
6.0%
12 Nov 2018
SAYER KEVIN R President, CEO & Chairman
Sold, plan not stated 6×
$1.63M 11,161 at 146.43
3.4%
9 Nov 2018
Abbey Donald EVP, Quality & Regulatory Afrs
Sold, plan not stated 3×
$1.58M 10,550 at 149.30
10.7%
9 Nov 2018
ACE HEATHER S SVP Human Resources
Sold, plan not stated 5×
$627.29K 4,258 at 147.32
6.1%
9 Nov 2018
Murphy Patrick Michael SVP, GC & Chief Compliance Off
Sold, plan not stated
$59.24K 400 at 148.11
1.3%
23 Oct 2018
Pacelli Steven Robert EVP, Strategy & Corp. Dev.
Sold, plan not stated 2×
$401.25K 3,114 at 128.85
2.7%
23 Oct 2018
DOUBLEDAY RICHARD EVP, Chief Commercial Officer · indirect
Sold, plan not stated 2×
$223.47K 1,736 at 128.72
9.1%
12 Oct 2018
Balo Andrew K EVP, Reg. Strategy, Clinical
Sold, plan not stated 2×
$623.93K 5,000 at 124.79
5.7%
10 Oct 2018
Murphy Patrick Michael SVP, GC & Chief Compliance Off
Sold, plan not stated
$48.88K 400 at 122.20
1.3%
8 Oct 2018
SAYER KEVIN R President, CEO & Chairman
Sold, plan not stated 2×
$1.39M 11,161 at 124.76
3.4%
1 Oct 2018
ALTMAN STEVEN R Director · indirect
Sold, plan not stated 7×
$339.13K 2,500 at 135.65
4.3%
28 Sep 2018
Leach Jacob Steven Chief Technology Officer · indirect
Sold, plan not stated 3×
$6.85M 47,600 at 143.95
100%
Sold half or more
24 Sep 2018
Pacelli Steven Robert EVP, Strategy & Corp. Dev.
Sold, plan not stated 5×
$439.84K 3,114 at 141.25
2.7%
24 Sep 2018
DOUBLEDAY RICHARD EVP, Chief Commercial Officer · indirect
Sold, plan not stated 5×
$245.13K 1,736 at 141.20
8.3%
14 Sep 2018
Balo Andrew K EVP, Reg. Strategy, Clinical
Sold, plan not stated 2×
$725.85K 5,000 at 145.17
5.4%
11 Sep 2018
Blackford Quentin S. EVP, CFO, PFO & PAO
Sold, plan not stated 4×
$1.24M 8,440 at 147.04
8.8%
10 Sep 2018
SAYER KEVIN R President, CEO & Chairman
Sold, plan not stated 5×
$3.66M 25,495 at 143.62
7.4%
10 Sep 2018
Blackford Quentin S. EVP, CFO, PFO & PAO
Sold, plan not stated
$1.03M 7,149 at 143.76
7.0%
10 Sep 2018
MOY JEFFREY SVP, Operations · indirect
Sold, plan not stated
$822.26K 5,736 at 143.35
25.6%
10 Sep 2018
Balo Andrew K EVP, Reg. Strategy, Clinical
Sold, plan not stated 2×
$803.16K 5,587 at 143.76
5.7%
10 Sep 2018
DOUBLEDAY RICHARD EVP, Chief Commercial Officer
Sold, plan not stated 2×
$788.21K 5,483 at 143.76
7.6%
10 Sep 2018
Pacelli Steven Robert EVP, Strategy & Corp. Dev.
Sold, plan not stated 2×
$788.21K 5,483 at 143.76
4.5%
10 Sep 2018
Leach Jacob Steven SVP, Research & Development
Sold, plan not stated 2×
$663.29K 4,614 at 143.76
4.7%
10 Sep 2018
MOY JEFFREY SVP, Operations
Sold, plan not stated 2×
$660.41K 4,594 at 143.76
6.7%
10 Sep 2018
Murphy Patrick Michael VP, Legal Aff & Chf Compl Ofcr
Sold, plan not stated 3×
$340.83K 2,372 at 143.69
7.0%
10 Sep 2018
Abbey Donald EVP, Quality & Regulatory Afrs
Sold, plan not stated
$331.07K 2,303 at 143.76
2.3%
10 Sep 2018
ACE HEATHER S SVP Human Resources
Sold, plan not stated
$263.36K 1,832 at 143.76
2.6%
24 Aug 2018
Leach Jacob Steven SVP, Research & Development
Sold, plan not stated 2×
$2.85M 20,577 at 138.32
17.2%
24 Aug 2018
ALTMAN STEVEN R Director · indirect
Sold, plan not stated
$682.36K 5,000 at 136.47
100%
Sold half or more
24 Aug 2018
FOLETTA MARK G Director · indirect
Sold, plan not stated
$137.50K 1,000 at 137.50
5.5%
23 Aug 2018
Pacelli Steven Robert EVP, Strategy & Corp. Dev.
Sold, plan not stated 4×
$435.84K 3,114 at 139.96
2.5%
23 Aug 2018
DOUBLEDAY RICHARD EVP, Chief Commercial Officer · indirect
Sold, plan not stated 3×
$361.83K 2,584 at 140.03
100%
Sold half or more
14 Aug 2018
Balo Andrew K EVP, Reg. Strategy, Clinical
Sold, plan not stated 2×
$621.25K 5,000 at 124.25
4.8%
Showing 451–500 of 605. ← Newer Page 10 of 13 Older →